Opiant Pharmaceuticals Inc – Indentures – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Indentures Filter

from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from 8-K 20 pages Registration Rights Agreement

from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from 8-K 3 pages 200,000,000 Authorized Shares, $0.001 Par Value Per Share Common Stock Dr. Roger Crystal, Chief Executive Officer Incorporated Under the Laws of the State of Delaware David O'toole, Secretary Opiant Pharmaceuticals, Inc